Literature DB >> 27234027

The use of extended criteria donors decreases one-year survival in high-risk lung recipients: A review of the United Network of Organ Sharing Database.

Matthew J Mulligan1, Pablo G Sanchez2, Charles F Evans2, Yan Wang3, Zachary N Kon2, Keshava Rajagopal2, Aldo T Iacono4, James S Gammie2, Bartley P Griffith2, Si M Pham5.   

Abstract

OBJECTIVE: The study objective was to investigate the impact of matching donor quality to recipient severity on survival after lung transplant.
METHODS: By using the Organ Procurement and Transplantation Network/United Network for Organ Sharing dataset, we analyzed lung transplant recipients from May 4, 2005, to December 31, 2012. By using adjusted Cox regressions, we identified extended criteria donors as those who had 1 or more of the following: age 65 years or more, smoking history of 20 pack-years or more, diabetes mellitus, or African-American race. All other donors were considered standard donors. Recipients were categorized by lung allocation score: lung allocation score less than 70 and lung allocation score 70 or greater. Our primary outcome was 1-year survival after lung transplantation.
RESULTS: Of the 10,995 lung recipients, 3792 (34%) received extended criteria donor organs. Extended criteria donors were associated with an increased hazard of death (hazard ratio [HR], 1.41; 95% confidence interval [CI], 1.26-1.56; P < .001). One-year survival was 87% and 82% (P < .001) for recipients with a lung allocation score less than 70 and 80% and 72% (P = .017) for recipients with a lung allocation score 70 or greater who received standard donor and extended criteria donor organs, respectively. In Cox regression models, the hazard of death was increased for recipients with a lung allocation score less than 70 + extended criteria donor (HR, 1.42; 95% CI, 1.27-1.60; P < .001), recipients with a lung allocation score 70 or greater + standard donor (HR, 1.37; 95% CI, 1.10-1.71; P = .005), and was the highest for recipients with a lung allocation score 70 or greater + extended criteria donor (HR, 1.81; 95% CI, 1.40-2.33; P < .001) compared with recipients with a lung allocation score less than 70 + standard donor.
CONCLUSIONS: Extended criteria donors are associated with reduced 1-year survival, and recipients with a lung allocation score 70 or greater who receive extended criteria donor organs have the lowest survival.
Copyright © 2016 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  extended lung donor; lung transplantation

Mesh:

Year:  2016        PMID: 27234027     DOI: 10.1016/j.jtcvs.2016.03.096

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  15 in total

1.  Reduced-flow ex vivo lung perfusion to rehabilitate lungs donated after circulatory death.

Authors:  Jared P Beller; Matthew R Byler; Dustin T Money; William Z Chancellor; Aimee Zhang; Yunge Zhao; Mark H Stoler; Adishesh K Narahari; Alexander Shannon; J Hunter Mehaffey; Curtis G Tribble; Victor E Laubach; Irving L Kron; Mark E Roeser
Journal:  J Heart Lung Transplant       Date:  2019-09-18       Impact factor: 10.247

2.  Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.

Authors:  Hrishikesh S Kulkarni; Wida S Cherikh; Daniel C Chambers; Victoria C Garcia; Ramsey R Hachem; Daniel Kreisel; Varun Puri; Benjamin D Kozower; Derek E Byers; Chad A Witt; Jennifer Alexander-Brett; Patrick R Aguilar; Laneshia K Tague; Yuka Furuya; G Alec Patterson; Elbert P Trulock; Roger D Yusen
Journal:  J Heart Lung Transplant       Date:  2018-09-25       Impact factor: 10.247

Review 3.  Evaluation and Management of the Potential Lung Donor.

Authors:  Andrew Courtwright; Edward Cantu
Journal:  Clin Chest Med       Date:  2017-08-31       Impact factor: 2.878

4.  Chest computed tomography imaging improves potential lung donor assessment.

Authors:  Jason M Gauthier; Andrew J Bierhals; Jingxia Liu; Keki R Balsara; Christine Frederiksen; Emily Gremminger; Ramsey R Hachem; Chad A Witt; Elbert P Trulock; Derek E Byers; Roger D Yusen; Patrick R Aguilar; Gary Marklin; Ruben G Nava; Benjamin D Kozower; Michael K Pasque; Bryan F Meyers; G Alexander Patterson; Daniel Kreisel; Varun Puri
Journal:  J Thorac Cardiovasc Surg       Date:  2018-11-24       Impact factor: 5.209

5.  Low-risk donor lungs optimize the post-lung transplant outcome for high lung allocation score patients.

Authors:  Takeshi Kurosaki; Kentaroh Miyoshi; Shinji Otani; Kentaro Imanishi; Seiichiro Sugimoto; Masaomi Yamane; Motomu Kobayashi; Shinichi Toyooka; Takahiro Oto
Journal:  Surg Today       Date:  2018-05-11       Impact factor: 2.549

6.  National Heart, Lung, and Blood Institute and American Association for Thoracic Surgery Workshop Report: Identifying collaborative clinical research priorities in lung transplantation.

Authors:  Michael S Mulligan; David Weill; R Duane Davis; Jason D Christie; Farhood Farjah; Jonathan P Singer; Matthew Hartwig; Pablo G Sanchez; Daniel Kreisel; Lorraine B Ware; Christian Bermudez; Ramsey R Hachem; Michael J Weyant; Cynthia Gries; Jeremiah W Awori Hayanga; Bartley P Griffith; Laurie D Snyder; Jonah Odim; J Matthew Craig; Neil R Aggarwal; Lora A Reineck
Journal:  J Thorac Cardiovasc Surg       Date:  2018-08-18       Impact factor: 5.209

7.  Outcomes and risk factors identification in urgent lung transplantation: a multicentric study.

Authors:  Marco Schiavon; Giulio Faggi; Lorenzo Rosso; Luca Luzzi; Giovanni Maria Comacchio; Dario Gregori; Mario Nosotti; Francesco Damarco; Andrea Dell'Amore; David Bennet; Antonella Fossi; Piero Paladini; Luigi Santambrogio; Federico Rea
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

8.  Early Graft Dysfunction after Lung Transplantation.

Authors:  Justin Rosenheck; Colleen Pietras; Edward Cantu
Journal:  Curr Pulmonol Rep       Date:  2018-10-22

9.  Aggressive pursuit and utilization of non-ideal donor lungs does not compromise post-lung transplant survival.

Authors:  Samantha E Halpern; Oliver K Jawitz; Vignesh Raman; Ashley Y Choi; John C Haney; Jacob A Klapper; Matthew G Hartwig
Journal:  Clin Transplant       Date:  2021-07-14       Impact factor: 3.456

Review 10.  Malignancy after lung transplantation.

Authors:  Osnat Shtraichman; Vivek N Ahya
Journal:  Ann Transl Med       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.